Drug Trial Radar · NCT03335072
Kebele Elimination of Trachoma for Ocular Health
Last checked: Nov 19, 2026Latest source record: Oct 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
320,000
Planned (sponsor's estimate)
Start
Feb 7, 2022
Primary completion
Mar 1, 2027
Study completion Mar 1, 2028
Sponsor
- Lead sponsor
- University of California, San FranciscoAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Eye Institute (NEI); Eyu-Ethiopia; Bahir Dar University
- First posted
- Nov 7, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
Conditions
- Trachoma
Interventions
AzithromycinDrug
Mass Drug Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular chlamydia measured in a population based age-stratified sample of the entire communityTime frame: 36 months
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
UCSF Proctor Foundation
San Francisco, California
Eyu-Ethiopia
Bahir Dar, Ethiopia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.